PTX3 and chronic obstructive pulmonary disease: The meta-analysis showed significantly higher serum PTX-3 levels in COPD patients compared to healthy controls (standardized mean difference [SMD]: 0.51, 95% confidence interval [CI]: 0.30–0.73, P < 0.001; I2 ═ 85%).